Menu
Riseup-PPD
  • About
    • Action Structure
    • Action Members
    • Action Partners
  • Working Groups
    • Working Group 1
    • Working Group 2
    • Working Group 3
    • Working Group 4
    • Working Group 5
    • Working Group 6
      • Team
    • COVID-19 Taskforce
  • Activities
    • Status of Events
    • MC Meetings
    • Training Schools
    • Workshops
    • ITC conference Grants
    • Virtual Networking Tools
    • International Conference 2023
    • International Conference 2022
      • Programme
      • Speakers
  • Calls
  • Dissemination
    • Research Publications
    • Presentations
    • Publication Guidelines
    • Press
    • Newsletter
    • Flyer
  • Contact
  • About
    • Action Structure
    • Action Members
    • Action Partners
  • Working Groups
    • Working Group 1
    • Working Group 2
    • Working Group 3
    • Working Group 4
    • Working Group 5
    • Working Group 6
      • Team
    • COVID-19 Taskforce
  • Activities
    • Status of Events
    • MC Meetings
    • Training Schools
    • Workshops
    • ITC conference Grants
    • Virtual Networking Tools
    • International Conference 2023
    • International Conference 2022
      • Programme
      • Speakers
  • Calls
  • Dissemination
    • Research Publications
    • Presentations
    • Publication Guidelines
    • Press
    • Newsletter
    • Flyer
  • Contact

​WG1: PREVENTION AND TREATMENT STRATEGIES IN PPD

​Leader: Sandra Nakić Radoš (Croatia)
Co-Leader: Ana Uka (Albania)

Previous leader (2019-2021): Ana Fonseca (Portugal)
Previous Co-Leader (2019-2021): Sandra Nakić Radoš (Croatia)

Objectives: Synthesize current knowledge concerning diagnosis criteria and strategies for prevention and treatment of PPD, including knowledge about well-established interventions and new lines of research, its cost-effectiveness and organizational impact.
Tasks: i) Review the state-of-the-art concerning diagnosis criteria, prevention, and treatment; ii) Identify other knowledge gaps; iii) Combine the available evidence and address the gaps in the field ; iv) Discuss new research ideas aiming for coordinated future projects in collaboration, focusing on novel effective procedures needed to support decision making on the selection of cost-effective programs; v) Propose guidelines for prevention and clinical intervention; vi) Provide training to researchers and health professionals working in perinatal settings. 

Milestones: WG Meetings; 3 TSs for researchers in systematic reviews/meta-analysis, principles and practice in clinical trials, and cost-effectiveness analysis in health; 2 TSs for health professionals in prevention of perinatal mental health disorders, and evidence-based PPD interventions; 2 Short Term Scientific Missions (STSMs) in clinical training; 2 Workshops (1 for primary care professionals; 1 for undergraduate students); Identify the gaps in the field and discuss new future projects in collaboration 

Deliverables: Report addressing the definition and diagnosis criteria of PPD, current needs and future directions for prevention, management and treatment of Peripartum Depression Disorder (consensus); Publication of systematic reviews/meta-analysis results in prevention and treatment strategies for Peripartum Depression Disorder; Proposals for concrete regional guidelines for prevention, clinical diagnosis, and treatment of PPD.
Powered by Create your own unique website with customizable templates.